Icon wraps up its $143.5M deal for Aptiv

Irish CRO Icon ($ICLR) has closed out its $143.5 million acquisition of Aptiv Solutions, a deal designed to amp up its technology and expand its presence in Japan. Icon has now absorbed the Reston, VA-headquartered CRO, which made its name assisting drug and device developers with planning and executing adaptive clinical trials, allowing sponsors to make data-driven decisions midstudy. Icon also gets Niphix, Aptiv's Japanese subsidiary, which focuses on work in oncology. Release

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

Genae's CEO says the transaction reflects recent focus on digital health and data-driven services.